_________ false

C002

טבע תעשיות פרמצבטיות בע"מ

2

Public

TEVA- PHARMACEUTICAL INDUSTRIES LTD

10205

Corporation no: 520013954

Stock Exchange/Market: NYSE

310

380

P.O.B 3190 , Petach Tikva 49131 , ,

Tel: 03-9267267 , 03-9267652 Fax: 03-9267519

E.mail address: tomer.amitai@teva.co.il

Reported via MAGNA: 05/06/2014

              Time of broadcast: 15:54 15:36:08

Reference: 2014-02-084384

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on TEVA ANNOUNCES NEW ORGANIZATIONAL STRUCTURE AND SENIOR LEADERSHIP CHANGES, ENABLING THE GLOBAL INTEGRATION OF THE COMPANY AND POSITIONING IT FOR SHORT- AND LONG-TERM VALUE CREATION APPOINTS SIGURDUR OLAFSSON AS PRESIDENT AND CEO OF NEWLY ESTABLISHED GLOBAL GENERIC MEDICINES GROUP.

ence_Announcement_June_5_2014_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):

Previous names of reporting entity:

Date of revision of form structure: 14/05/2014

Name of the Signatory: : Bergwerk Dov , Position of Signatory in the reporting corporation: Vice President & General Counsel , Name of Employer Company: .

Basel Telephone: 03-9267513 , Facsimile: 03-9267429 , E-mail: einat.barzilai@teva.co.il 1